Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

被引：58

作者：

Evans, D. G. ^{[1
,2
]}

Howell, A. ^{[1
,3
]}

Ward, D. ^{[4
]}

Lalloo, F. ^{[2
]}

Jones, J. L. ^{[5
]}

Eccles, D. M. ^{[6
]}

机构：

[1] Univ Hosp S Manchester NHS Trust, Genesis Prevent Ctr, Manchester, Lancs, England

[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, St Marys Hosp, Manchester M13 9WL, Lancs, England

[3] Christie NHS Trust, CR UK Dept Med Oncol, Manchester, Lancs, England

[4] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury NHS Fdn Trust, Salisbury, Wilts, England

[5] Barts & Univ London, Sch Med & Dent, John Vane Sci Ctr, Tumour Biol Dept, London, England

[6] Univ Southampton, Fac Med, Southampton Univ Hosp Trust, Southampton SO9 5NH, Hants, England

来源：

JOURNAL OF MEDICAL GENETICS | 2011年 / 48卷 / 08期

关键词：

BOADICEA; OUTCOMES; WOMEN;

D O I：

10.1136/jmedgenet-2011-100006

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：520 / 522

页数：3

共 14 条

[1] Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation:: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics [J].

Antoniou, A. C. ;

Hardy, R. ;

Walker, L. ;

Evans, D. G. ;

Shenton, A. ;

Eeles, R. ;

Shanley, S. ;

Pichert, G. ;

Izatt, L. ;

Rose, S. ;

Douglas, F. ;

Eccles, D. ;

Morrison, P. J. ;

Scott, J. ;

Zimmern, R. L. ;

Easton, D. F. ;

Pharoah, P. D. P. .

JOURNAL OF MEDICAL GENETICS, 2008, 45 (07) :425-431

[2] The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions [J].

Antoniou, A. C. ;

Cunningham, A. P. ;

Peto, J. ;

Evans, D. G. ;

Lalloo, F. ;

Narod, S. A. ;

Risch, H. A. ;

Eyfjord, J. E. ;

Hopper, J. L. ;

Southey, M. C. ;

Olsson, H. ;

Johannsson, O. ;

Borg, A. ;

Passini, B. ;

Radice, P. ;

Manoukian, S. ;

Eccles, D. M. ;

Tang, N. ;

Olah, E. ;

Anton-Culver, H. ;

Warner, E. ;

Lubinski, J. ;

Gronwald, J. ;

Gorski, B. ;

Tryggvadottir, L. ;

Syrjakoski, K. ;

Kallioniemi, O-P ;

Eerola, H. ;

Nevanlinna, H. ;

Pharoah, P. D. P. ;

Easton, D. F. .

BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1457-1466

[3] Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists [J].

Badve, Sunil ;

Dabbs, David J. ;

Schnitt, Stuart J. ;

Baehner, Frederick L. ;

Decker, Thomas ;

Eusebi, Vincenzo ;

Fox, Stephen B. ;

Ichihara, Shu ;

Jacquemier, Jocelyne ;

Lakhani, Sunil R. ;

Palacios, Jose ;

Rakha, Emad A. ;

Richardson, Andrea L. ;

Schmitt, Fernando C. ;

Tan, Puay-Hoon ;

Tse, Gary M. ;

Weigelt, Britta ;

Ellis, Ian O. ;

Reis-Filho, Jorge S. .

MODERN PATHOLOGY, 2011, 24 (02) :157-167

[4] Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women [J].

Comen, E. ;

Davids, M. ;

Kirchhoff, T. ;

Hudis, C. ;

Offit, K. ;

Robson, M. .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :185-190

[5] Prospective study of outcomes in sporadic versus hereditary breast cancer (POSH): study protocol [J].

Eccles, Diana ;

Gerty, Sue ;

Simmonds, Peter ;

Hammond, Victoria ;

Ennis, Sarah ;

Altman, Douglas G. .

BMC CANCER, 2007, 7 (1)

[6] Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status [J].

Evans, D. G. R. ;

Moran, A. ;

Hartley, R. ;

Dawson, J. ;

Bulman, B. ;

Knox, F. ;

Howell, A. ;

Lalloo, F. .

BRITISH JOURNAL OF CANCER, 2010, 102 (07) :1091-1098

[7] Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing [J].

Evans, D. G. R. ;

Lalloo, F. ;

Cramer, A. ;

Jones, E. A. ;

Knox, F. ;

Amir, E. ;

Howell, A. .

JOURNAL OF MEDICAL GENETICS, 2009, 46 (12) :811-817

[8] Genetic testing for familial/hereditary breast cancer - Comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany [J].

Gadzicki D. ;

Evans D.G. ;

Harris H. ;

Julian-Reynier C. ;

Nippert I. ;

Schmidtke J. ;

Tibben A. ;

Van Asperen C.J. ;

Schlegelberger B. .

Journal of Community Genetics, 2011, 2 (2) :53-69

[9] Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer [J].

Gonzalez-Angulo, Ana M. ;

Timms, Kirsten M. ;

Liu, Shuying ;

Chen, Huiqin ;

Litton, Jennifer K. ;

Potter, Jennifer ;

Lanchbury, Jerry S. ;

Stemke-Hale, Katherine ;

Hennessy, Bryan T. ;

Arun, Banu K. ;

Hortobagyi, Gabriel N. ;

Do, Kim-Anh ;

Mills, Gordon B. ;

Meric-Bernstam, Funda .

CLINICAL CANCER RESEARCH, 2011, 17 (05) :1082-1089

[10] Metastatic Behavior of Breast Cancer Subtypes [J].

Kennecke, Hagen ;

Yerushalmi, Rinat ;

Woods, Ryan ;

Cheang, Maggie Chon U. ;

Voduc, David ;

Speers, Caroline H. ;

Nielsen, Torsten O. ;

Gelmon, Karen .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3271-3277

← 1 2 →